title: How should access to antiretroviral treatment be measured?
authors.affiliation: Centre for Infectious Disease Epidemiology and Research, University of Cape Town, Anzio Road, Observatory, 7925, Cape Town, South Africa. Leigh.Johnson@uct.ac.za
authors.forename: Leigh F
authors.initials: LF
authors.lastname: Johnson
authors.forename: Andrew
authors.initials: A
authors.lastname: Boulle
mesh_terms: D019380:Anti-HIV Agents / Q000191:economics / Q000627:therapeutic use*; D019985:Benchmarking / Q000379:methods* / Q000592:standards / Q000706:statistics & numerical data; D018791:CD4 Lymphocyte Count; D014943:Global Health; D015658:HIV Infections / Q000188:drug therapy* / Q000191:economics / Q000453:epidemiology; D006297:Health Services Accessibility / Q000592:standards / Q000706:statistics & numerical data*; D006301:Health Services Needs and Demand / Q000191:economics / Q000592:standards / Q000706:statistics & numerical data; D006801:Humans; D013019:South Africa / Q000453:epidemiology; D014480:United Nations; D014944:World Health Organization
chemical_list: D019380:Anti-HIV Agents